Medifron DBT to raise 13 bln won via stock sale
All News
18:10 June 22, 2022
SEOUL, June 22 (Yonhap) -- Medifron DBT Co.on Wednesday announced that it will sell stocks to raise 13 billion won (US$10 million). The proceeds from the stock offering will be used primarily to finance its operations.
According to a regulatory filing, the company will issue some 8.66 million preferred shares at a price of 1,500 won per share. The stocks will be sold to the investors that the firm designated.
(END)
Keywords
Issue Keywords
Most Liked
-
(Yonhap Interview) Samsung has substantial upside potential on sound fundamentals: chief analyst
-
BTS vows full support for Busan's World Expo bid
-
(6th LD) S. Korea successfully launches homegrown space rocket in second attempt
-
VIVIZ to drop 2nd EP next month
-
BTS' Jungkook drops collaborative single with U.S. singer-songwriter
Most Saved
-
(Yonhap Interview) Samsung has substantial upside potential on sound fundamentals: chief analyst
-
S. Korea prepares to launch homegrown space rocket after failed attempt last year
-
(LEAD) On Korean War anniversary, S. Korea vows stern response to N. Korean provocations
-
(6th LD) S. Korea successfully launches homegrown space rocket in second attempt
-
Samsung expected to announce mass production of 3nm chip next week
-
Son Ye-jin pregnant, expecting first baby with Hyun Bin
-
Seoul records highest-ever morning low for June
-
Huge search under way for missing family of 3 on southwestern island
-
Police chief offers to resign after Yoon slams reshuffle announcement flip-flopping
-
Yoon to depart for Spain to attend NATO summit